18F-Fludeoxyglucose

What 18F-Fludeoxyglucose Means in Everyday Medical Language

18F-Fludeoxyglucose, often called FDG, is a type of sugar that has a tiny amount of radioactivity added to it. This radioactive sugar acts like regular glucose, which is the main energy source for cells in the body. When FDG is injected into a person’s bloodstream, it travels through the body and is absorbed by cells that need energy. Because cancer cells often grow quickly and use more energy than normal cells, they tend to take up more FDG. Special cameras called PET scanners detect the radiation from FDG and create images showing where the sugar has collected.

Why 18F-Fludeoxyglucose Can Matter in Cancer Care

FDG is important in cancer care because it helps doctors find tumors and see how active they are. It can show where cancer might be located and whether it has spread to other parts of the body. Doctors also use FDG-PET scans to check how well treatment is working by seeing if cancer cells are still active after therapy. This information helps guide treatment decisions and planning.

What Patients Might See or Experience When FDG Is Used

If your doctor orders an FDG-PET scan, you will receive an injection of the radioactive sugar before the scan. The scan itself is painless, but you will need to lie still for a period of time while images are taken. After the scan, you might hear your care team talk about areas of increased FDG uptake, which means places where more sugar was absorbed. These areas may suggest cancer or other conditions with active cells.

What FDG Uptake Does Not Automatically Mean

It’s important to know that seeing FDG uptake on a scan does not always mean cancer is present. Some infections, inflammation, or other non-cancerous conditions can also absorb FDG and appear as bright spots on the scan. Because of this, doctors interpret FDG-PET results carefully, considering other tests, biopsy results, and your symptoms before making a diagnosis.

How Doctors Use FDG-PET Scans in Diagnosis and Treatment

Doctors use FDG-PET scans to help find tumors, determine how far cancer has spread (called staging), and monitor treatment response. For example, after chemotherapy or radiation, a PET scan can show if cancer cells are still active or if the area has returned to normal. This helps doctors decide if treatment should continue, change, or stop.

Common Questions Patients Can Ask Their Care Team

You might find it helpful to ask why an FDG-PET scan is recommended, what the scan will show, and how to understand areas of increased FDG uptake. It’s also reasonable to ask about any risks or side effects from the radioactive sugar and what the results might mean for your care plan.

Understanding FDG in Context and Next Steps

FDG is closely linked to PET scans and may appear in medical reports, treatment plans, or clinical trial descriptions. Remember that FDG-PET scans are one part of a larger diagnostic process and do not provide a diagnosis alone. If you see this term in your medical records or hear it during your care, the best next step is to talk openly with your healthcare team. They can explain what the scan results mean for your specific situation and help you understand your diagnosis and treatment options.

This information is for education and does not replace personalized medical advice. Each person’s case is unique, so decisions about imaging and treatment should always be made with your doctors.